Literature DB >> 32572529

ICU beds: less is more? Not sure.

Jason Phua1,2, Madiha Hashmi3, Rashan Haniffa4,5,6.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32572529      PMCID: PMC7306568          DOI: 10.1007/s00134-020-06162-8

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
There exists a huge variation in intensive-care unit (ICU) beds across ICUs, hospitals, and countries. This begs the question of just what the optimal number of ICU beds is, a conundrum which has been thrown into the spotlight with the coronavirus disease 2019 (COVID-19) [1]. The hypothesis that less ICU beds is more is supported by various arguments [2]. There is evidence that healthcare systems with a relative abundance of ICU beds tend to use these beds more liberally, even for patients who may not benefit from intensive care [3]. For example, in a study of ICU patients in the United States in 2008, only about one-quarter required mechanical ventilation [4]. This has several consequences. First, overly enthusiastic use of ICUs is not without risks. The incidence of medical errors and adverse events among ICU patients, sometimes from unnecessary treatments, ranges from 15 to 51% [5]. Second, the line between intensive care and end-of-life care can become excessively grey, with more people spending their last days in the ICUs. This is despite evidence that most people prefer to die at home [6]. Third, ICU beds are an expensive resource which contribute substantially to healthcare costs [7]. When unaffordable and, therefore, inaccessible, they can lead to guilt in families of the critically ill, especially in resource-limited settings. These arguments are sound, but have to be considered concurrently with opposing views [8]. A lack of ICU beds creates a capacity strain, conceptually defined as a mismatch between demand and supply. It forces clinicians to aggressively ration. The consequences are denial of or delay in admission of ill patients who would have benefited from intensive care, and out-of-hours discharge of existing patients from the ICU, all of which have been associated with increased mortality [9]. These issues have always existed, but were made painfully clear with the surge of COVID-19 in many overwhelmed healthcare systems [10]. We believe that both the statements “less is more” and “less is not more” for ICU beds are too simplistic. The solution to the question of the optimal number of ICU beds is best provided by a Goldilocks answer: “just the right amount” in the context of each ICU, hospital, and country. But how is one to determine this number? First, a nuanced understanding of what exactly is an ICU is required. The World Federation of Intensive and Critical Care suggested that “an ICU is based in a defined geographic area of a hospital, and an organised system for the provision of care to critically ill patients that provides intensive and specialised medical and nursing care, an enhanced capacity for monitoring, and multiple modalities of physiologic organ support to sustain life during a period of acute organ system insufficiency” [11]. This attempt to standardise definitions notwithstanding, intensive care is provided in different settings across the world today, from ICUs capable of extracorporeal support in resource-rich urban areas to makeshift facilities without mechanical ventilators in resource-limited rural areas [12]. Second, ICUs are not just a static collection of infrastructure and equipment, but a dynamic force driven by physicians, nurses, and allied health professionals. Units with many high-acuity beds but insufficient trained staff risk compromising patient outcomes. Intensivist-to-patient ratios lower than 1:15 adversely affect patient care and staff well-being in academic medical ICUs [13]. One-to-one nursing is clearly safer than one-to-many, but critical care nursing shortages are pervasive even in high-income settings. On the other hand, units with mostly low-acuity patients and too much manpower risk deskilling staff, who then struggle to cope when the sickest of the sick present. Thus, while it has been suggested that bed occupancy rates of 70–75% are optimal [14], estimation of bed requirements must take into account the availability and training of staff. Third, ICUs exist within hospitals as part of a complex healthcare system and cannot be seen in isolation. Tertiary hospitals that provide more complex treatments and perform more high-risk surgeries will require more ICU beds. Hospitals that have invested in providing “critical care without walls” will require less ICU beds. Possibilities include the flexible use of high dependency units, remodelled general wards, post-anaesthesia care units, emergency departments, and deployable field units for high-acuity patients [1]. Many hospitals have also invested in telemedicine, which is postulated to reduce ICU length of stay and, hence, bed requirements [15]. Rapid response systems, often advocated in the same vein, have not been associated with a decrease in ICU admissions [16]. Fourth, ICU bed capacity varies widely across countries. Low- and middle-income countries have significantly fewer ICU beds than high-income ones. For example, while Uganda and Bangladesh, respectively, have 0.1 and 0.8 adult critical care beds per 100,000 population, Taiwan and the United States, respectively, have 28.5 and 27.0 [17]. Clearly, rationing of ICU beds is the norm in resource-limited settings. While it is tempting to call for more ICU beds in these countries, governments, policy makers, and the intensive-care community will have to balance this with investments in more basic healthcare [12]. Cultural and societal views of the role of ICUs in end-of-life care also differ widely across countries, and must be factored into any discussion on ICU bed capacity [18]. Finally, demand for ICU beds is not constant, but surges during pandemics and declines during peacetime [1]. Many have been struck by how new ICUs and ICU beds had to be created literally overnight to deal with COVID-19 in places like Wuhan and Lombardy [19, 20]. After the pandemic eases, much of the infrastructure remodelled and created will likely form the surge capacity for future outbreaks, while many of the ventilators procured and manufactured will likely enter a national or local stockpile. How much to pre-emptively invest in such capacity and stockpiles is a matter of judgment. The cost–benefit at a societal level—while acknowledging the tragedy of each life lost at a family level due to a lack of ICU resources—needs contemplation. The implications at the hospital level—while recognising the need to complement any hardware with skilled human resource through continuing education and clinical training—require consideration. In conclusion, the adverse impact of extremes of ICU bed capacity is clear. Too few, and patient outcomes are compromised. Too many, and healthcare costs balloon, while possibly also worsening patient outcomes. What is too few or too many is, however, difficult to define. It depends on the very definition of an ICU bed, the acuity and staffing of each ICU, the services and facilities of each hospital, the resources and culture of each country, and the waxing and waning of pandemics.
  20 in total

1.  A comparison of critical care research funding and the financial burden of critical illness in the United States.

Authors:  Craig M Coopersmith; Hannah Wunsch; Mitchell P Fink; Walter T Linde-Zwirble; Keith M Olsen; Marilyn S Sommers; Kanwaljeet J S Anand; Kathryn M Tchorz; Derek C Angus; Clifford S Deutschman
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

Review 2.  Optimal occupancy in the ICU: a literature review.

Authors:  Laura T Tierney; Karena M Conroy
Journal:  Aust Crit Care       Date:  2013-12-27       Impact factor: 2.737

3.  Critical Care Bed Capacity in Asian Countries and Regions.

Authors:  Jason Phua; Mohammad Omar Faruq; Atul P Kulkarni; Ike Sri Redjeki; Khamsay Detleuxay; Naranpurev Mendsaikhan; Kyi Kyi Sann; Babu Raja Shrestha; Madiha Hashmi; Jose Emmanuel M Palo; Rashan Haniffa; Chunting Wang; Seyed Mohammad Reza Hashemian; Aidos Konkayev; Mohd Basri Mat Nor; Boonsong Patjanasoontorn; Khalid Mahmood Khan Nafees; Lowell Ling; Masaji Nishimura; Maher Jaffer Al Bahrani; Yaseen M Arabi; Chae-Man Lim; Wen-Feng Fang
Journal:  Crit Care Med       Date:  2020-05       Impact factor: 7.598

4.  Fair Allocation of Scarce Medical Resources in the Time of Covid-19.

Authors:  Ezekiel J Emanuel; Govind Persad; Ross Upshur; Beatriz Thome; Michael Parker; Aaron Glickman; Cathy Zhang; Connor Boyle; Maxwell Smith; James P Phillips
Journal:  N Engl J Med       Date:  2020-03-23       Impact factor: 91.245

5.  Clinical and Economic Outcomes of Telemedicine Programs in the Intensive Care Unit: A Systematic Review and Meta-Analysis.

Authors:  Jing Chen; Dalong Sun; Weiming Yang; Mingli Liu; Shufan Zhang; Jinhua Peng; Chuancheng Ren
Journal:  J Intensive Care Med       Date:  2017-08-22       Impact factor: 3.510

6.  Heterogeneity and changes in preferences for dying at home: a systematic review.

Authors:  Barbara Gomes; Natalia Calanzani; Marjolein Gysels; Sue Hall; Irene J Higginson
Journal:  BMC Palliat Care       Date:  2013-02-15       Impact factor: 3.234

7.  ICU beds: less is more? No.

Authors:  Dylan W de Lange; Marcio Soares; David Pilcher
Journal:  Intensive Care Med       Date:  2020-05-26       Impact factor: 17.440

8.  Impact on mortality of prompt admission to critical care for deteriorating ward patients: an instrumental variable analysis using critical care bed strain.

Authors:  Steve Harris; Mervyn Singer; Colin Sanderson; Richard Grieve; David Harrison; Kathryn Rowan
Journal:  Intensive Care Med       Date:  2018-05-07       Impact factor: 17.440

Review 9.  Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations.

Authors:  Jason Phua; Li Weng; Lowell Ling; Moritoki Egi; Chae-Man Lim; Jigeeshu Vasishtha Divatia; Babu Raja Shrestha; Yaseen M Arabi; Jensen Ng; Charles D Gomersall; Masaji Nishimura; Younsuck Koh; Bin Du
Journal:  Lancet Respir Med       Date:  2020-04-06       Impact factor: 30.700

10.  The Urge to Build More Intensive Care Unit Beds and Ventilators: Intuitive but Errant.

Authors:  Scott D Halpern; Franklin G Miller
Journal:  Ann Intern Med       Date:  2020-05-07       Impact factor: 25.391

View more
  4 in total

1.  Clinical course and factors associated with outcomes among 1904 patients hospitalized with COVID-19 in Germany: an observational study.

Authors:  Irit Nachtigall; Pavlina Lenga; Katarzyna Jóźwiak; Petra Thürmann; Andreas Meier-Hellmann; Ralf Kuhlen; Joerg Brederlau; Torsten Bauer; Juergen Tebbenjohanns; Karin Schwegmann; Michael Hauptmann; Julius Dengler
Journal:  Clin Microbiol Infect       Date:  2020-08-18       Impact factor: 8.067

Review 2.  The story of critical care in Asia: a narrative review.

Authors:  Jason Phua; Chae-Man Lim; Mohammad Omar Faruq; Khalid Mahmood Khan Nafees; Bin Du; Charles D Gomersall; Lowell Ling; Jigeeshu Vasishtha Divatia; Seyed Mohammad Reza Hashemian; Moritoki Egi; Aidos Konkayev; Mohd Basri Mat-Nor; Gentle Sunder Shrestha; Madiha Hashmi; Jose Emmanuel M Palo; Yaseen M Arabi; Hon Liang Tan; Rohan Dissanayake; Ming-Cheng Chan; Chairat Permpikul; Boonsong Patjanasoontorn; Do Ngoc Son; Masaji Nishimura; Younsuck Koh
Journal:  J Intensive Care       Date:  2021-10-07

3.  A hybrid Neural Network-SEIR model for forecasting intensive care occupancy in Switzerland during COVID-19 epidemics.

Authors:  Riccardo Delli Compagni; Zhao Cheng; Stefania Russo; Thomas P Van Boeckel
Journal:  PLoS One       Date:  2022-03-03       Impact factor: 3.240

Review 4.  Establishment of a high-dependency unit in Malawi.

Authors:  Ben Morton; Ndaziona Peter Banda; Edna Nsomba; Clara Ngoliwa; Sandra Antoine; Joel Gondwe; Felix Limbani; Marc Yves Romain Henrion; James Chirombo; Tim Baker; Patrick Kamalo; Chimota Phiri; Leo Masamba; Tamara Phiri; Jane Mallewa; Henry Charles Mwandumba; Kwazizira Samson Mndolo; Stephen Gordon; Jamie Rylance
Journal:  BMJ Glob Health       Date:  2020-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.